EUVIMEDEUVIMED entdecken
Crossref

Lipid-Based Nanocarriers for Acne Treatment: Current Progress and Clinical Feasibility

Ayda Rajabi, Azizeh Rahmani Del Bakhshayesh, Leila Hosseini, Azizeh Farshbaf-khalili, Halimeh Amirazad, Amélia C. F. Vieira, Soraya Babaie, Ana Cláudia Paiva-Santos

Advanced Pharmaceutical Bulletin · 01.07.2026

DOI: 10.34172/apb.47085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 01.07.2026. Verfasst von Ayda Rajabi und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acne vulgaris, a widespread inflammatory skin disorder, affects millions globally and is particularly common among teenagers and young adults. Acne arises due to a multifactorial interplay of genetic predisposition, hormonal fluctuations, environmental influences, and microbial activity, often complicating treatment; and is characterized by the development of various skin lesions, including comedones, papules, pustules, nodules, and cysts. These manifestations typically appear in areas with high sebaceous gland density, such as the face, neck, chest, and upper back. Conventional therapies such as antibiotics, retinoids, and hormonal modulators face challenges including side effects, antimicrobial resistance, and inconsistent patient adherence. Drug delivery systems utilizing nanotechnology show significant potential, particularly through lipid-based carriers such as liposomes, niosomes and solid lipid nanoparticles (SLNs). These systems optimize therapeutic efficacy by improving absorption rates, enabling controlled and prolonged drug release, and reducing localized irritation. This review examines acne’s biological mechanisms, evaluates existing treatments, and explores lipid nanoparticle technology as a means to refine targeted therapies, paving the way for advancements in personalized skincare.

Zitieren

APA

Rajabi, A., Bakhshayesh, A. R. D., Hosseini, L., Farshbaf-khalili, A., Amirazad, H., Vieira, A. C. F., Babaie, S., & Paiva-Santos, A. C. (2026). Lipid-Based Nanocarriers for Acne Treatment: Current Progress and Clinical Feasibility. Advanced Pharmaceutical Bulletin. https://doi.org/10.34172/apb.47085

Vancouver

Rajabi A, Bakhshayesh ARD, Hosseini L, Farshbaf-khalili A, Amirazad H, Vieira ACF, et al. Lipid-Based Nanocarriers for Acne Treatment: Current Progress and Clinical Feasibility. Advanced Pharmaceutical Bulletin. 2026. doi:10.34172/apb.47085

BibTeX
@article{Rajabi2026,
  author = {Rajabi, Ayda and Bakhshayesh, Azizeh Rahmani Del and Hosseini, Leila and Farshbaf-khalili, Azizeh and Amirazad, Halimeh and Vieira, Amélia C. F. and Babaie, Soraya and Paiva-Santos, Ana Cláudia},
  title = {Lipid-Based Nanocarriers for Acne Treatment: Current Progress and Clinical Feasibility},
  journal = {Advanced Pharmaceutical Bulletin},
  year = {2026},
  doi = {10.34172/apb.47085}
}
Kostenlos starten →